A Phase II Trial of Neoadjuvant Erlotinib (TARCEVA®) Followed by Surgery for Selected Patients with Stage IIIA, N2-Positive Non-Small Cell Lung Cancer

被引：0
|
作者：
Lim, Taekyu [1 ]
Baek, Kyung Kee [1 ]
Yi, Jun Ho [1 ]
Sin, Jong-Mu [1 ]
Lee, Jeeyun [1 ]
Park, Yeon Hee [1 ]
Ahn, Jin Seok [1 ]
Ahn, Myung-Ju [1 ]
Park, Keunchil [1 ]
机构：
[1] Samsun Med Ctr, Dept Hematol Oncol, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S394 / S394
页数：1
相关论文
共 50 条
  • [41] Management of Stage IIIA (N2) Non-Small Cell Lung Cancer
    Gillaspie, Erin A.
    Wigle, Dennis A.
    THORACIC SURGERY CLINICS, 2016, 26 (03) : 271 - +
  • [42] Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer
    Zheng, Difan
    Ye, Ting
    Hu, Hong
    Zhang, Yawei
    Sun, Yihua
    Xiang, Jiaqing
    Chen, Haiquan
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (04): : 1814 - +
  • [43] Neoadjuvant strategy for stage IIIA-N2 non-small cell lung cancer: chemoradiation or chemotherapy alone?
    Situ, Dongrong
    Lin, Yongbin
    JOURNAL OF THORACIC DISEASE, 2017, 9 (09) : 2746 - 2748
  • [44] Survival of Patients with Unsuspected N2 (Stage IIIA) Non-Small Cell Lung Cancer
    Yamamichi, Takashi
    Harada, Masahiko
    Hishima, Tsunekazu
    Asakawa, Ayaka
    Okui, Masayuki
    Horio, Hirotoshi
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S768 - S768
  • [45] SURVIVAL OF PATIENTS WITH UNSUSPECTED N2 (STAGE IIIA) NON-SMALL CELL LUNG CANCER
    Park, Chang Kwon
    Lee, Deok Heon
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S883 - S883
  • [46] Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: A prospective study
    Cerfolio, Robert James
    Bryant, Ayesha S.
    Ojha, Buddhiwardhan
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2006, 131 (06): : 1229 - 1235
  • [47] Neoadjuvant treatment with Taxol®-carboplatin in elderly patients with non-small cell lung cancer stage IIIA N2 disease
    Castellon Rubio, V. E.
    Carrillo Ramos, J.
    Gonzalez Flores, E.
    Gonzalez Astorga, B.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S347 - S347
  • [48] Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer
    Chen, Yulong
    Yan, Bo
    Xu, Feng
    Hui, Zhenzhen
    Zhao, Gang
    Liu, Jie
    Zhang, Huan
    Zeng, Ziqing
    Zhang, Ran
    Provencio, Mariano
    Ren, Xiubao
    You, Jian
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (05) : 2193 - +
  • [49] Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial
    Girard, Nicolas
    Mornex, Francoise
    Douillard, Jean-Yves
    Bossard, Nadine
    Quoix, Elisabeth
    Beckendorf, Veronique
    Grunenwald, Dominique
    Amour, Elodie
    Milleron, Bernard
    LUNG CANCER, 2010, 69 (01) : 86 - 93
  • [50] Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer
    Zhang, Peng
    Dai, Jie
    Sun, Fenghuan
    Xia, Haoran
    He, WenXin
    Duan, Liang
    Liu, Ming
    Zhao, Deping
    Zhu, Yuming
    Jiang, Gening
    ANNALS OF THORACIC SURGERY, 2022, 114 (03): : 949 - 958
12345